Rochester, MN: The administration of synthetic THC (aka dronabinol) decreases colonic motility compared to placebo in patients with irritable bowel syndrome (IBS), according to clinical trial data to be published in the journal Gastroenterology. Investigators at the...
The use of cannabis is common among patients with inflammatory bowel disease (IBD), according to survey data to be published in the European Journal of Gastroenterology and Hepatology. An international team of researchers from Mount Sinai Hospital in Toronto and the...
Baltimore, MD: The stimulation of a specific endocannabinoid receptor by a synthetic cannabinoid agonist significantly reduces the desire for cocaine, according to preclinical data published online in the scientific journal Nature Neuroscience. Investigators at the...
Preclinical data recently published in the Journal of Clinical Investigation demonstrating that cannabinoids may spur brain cell growth has reignited the international debate regarding the impact of marijuana on the brain. However, unlike previous pseudo-scientific...
Madrid, Spain: Cannabis’ active components show promise in halting the progression of certain neurodegerative disorders and should be evaluated in clinical trials, according to a review published online in the British Journal of Pharmacology. An international...
